1. Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14.
- Author
-
Wang Q, Bardgett ME, Wong M, Wozniak DF, Lou J, McNeil BD, Chen C, Nardi A, Reid DC, Yamada K, and Ornitz DM
- Subjects
- Animals, Ataxia genetics, Ataxia physiopathology, Axons pathology, Basal Ganglia growth & development, Basal Ganglia metabolism, Basal Ganglia physiopathology, Brain growth & development, Brain physiopathology, Cell Movement genetics, Cerebellum growth & development, Cerebellum metabolism, Cerebellum physiopathology, Chorea genetics, Chorea physiopathology, Cocaine pharmacology, Dopamine Agonists adverse effects, Female, Fibroblast Growth Factors genetics, Gene Targeting, Male, Mice, Mice, Knockout, Mitogen-Activated Protein Kinases drug effects, Mitogen-Activated Protein Kinases metabolism, Neostriatum growth & development, Neostriatum metabolism, Neostriatum physiopathology, Proto-Oncogene Proteins c-fos drug effects, Proto-Oncogene Proteins c-fos metabolism, Substantia Nigra growth & development, Substantia Nigra metabolism, Substantia Nigra physiopathology, beta-Galactosidase genetics, Ataxia metabolism, Axonal Transport genetics, Axons metabolism, Brain metabolism, Chorea metabolism, Fibroblast Growth Factors deficiency
- Abstract
Fibroblast growth factor 14 (FGF14) belongs to a distinct subclass of FGFs that is expressed in the developing and adult CNS. We disrupted the Fgf14 gene and introduced an Fgf14(N-beta-Gal) allele that abolished Fgf14 expression and generated a fusion protein (FGF14N-beta-gal) containing the first exon of FGF14 and beta-galactosidase. Fgf14-deficient mice were viable, fertile, and anatomically normal, but developed ataxia and a paroxysmal hyperkinetic movement disorder. Neuropharmacological studies showed that Fgf14-deficient mice have reduced responses to dopamine agonists. The paroxysmal hyperkinetic movement disorder phenocopies a form of dystonia, a disease often associated with dysfunction of the putamen. Strikingly, the FGF14N-beta-gal chimeric protein was efficiently transported into neuronal processes in the basal ganglia and cerebellum. Together, these studies identify a novel function for FGF14 in neuronal signaling and implicate FGF14 in axonal trafficking and synaptosomal function.
- Published
- 2002
- Full Text
- View/download PDF